37 CFR 1.555 — Information material to patentability in ex parte reexamination and inter partes reexamination proceedings
Ninth Edition, Revision 01.2024
- (a) A patent by its very nature is affected with a public interest. The public interest is best served, and the most effective reexamination occurs when, at the time a reexamination proceeding is being conducted, the Office is aware of and evaluates the teachings of all information material to patentability in a reexamination proceeding. Each individual associated with the patent owner in a reexamination proceeding has a duty of candor and good faith in dealing with the Office, which includes a duty to disclose to the Office all information known to that individual to be material to patentability in a reexamination proceeding. The individuals who have a duty to disclose to the Office all information known to them to be material to patentability in a reexamination proceeding are the patent owner, each attorney or agent who represents the patent owner, and every other individual who is substantively involved on behalf of the patent owner in a reexamination proceeding. The duty to disclose the information exists with respect to each claim pending in the reexamination proceeding until the claim is cancelled. Information material to the patentability of a cancelled claim need not be submitted if the information is not material to patentability of any claim remaining under consideration in the reexamination proceeding. The duty to disclose all information known to be material to patentability in a reexamination proceeding is deemed to be satisfied if all information known to be material to patentability of any claim in the patent after issuance of the reexamination certificate was cited by the Office or submitted to the Office in an information disclosure statement. However, the duties of candor, good faith, and disclosure have not been complied with if any fraud on the Office was practiced or attempted or the duty of disclosure was violated through bad faith or intentional misconduct by, or on behalf of, the patent owner in the reexamination proceeding. Any information disclosure statement must be filed with the items listed in § 1.98(a) as applied to individuals associated with the patent owner in a reexamination proceeding, and should be filed within two months of the date of the order for reexamination, or as soon thereafter as possible.
- (b) Under this section, information is material to
patentability in a reexamination proceeding when it is not
cumulative to information of record or being made of record in the
reexamination proceeding, and
- (1) It is a patent or printed publication that establishes, by itself or in combination with other patents or printed publications, a prima facie case of unpatentability of a claim; or
- (2) It refutes, or is inconsistent with, a
position the patent owner takes in:
- (i) Opposing an argument of unpatentability relied on by the Office, or
- (ii) Asserting an argument of patentability.
A prima facie case of unpatentability of a claim pending in a reexamination proceeding is established when the information compels a conclusion that a claim is unpatentable under the preponderance of evidence, burden-of-proof standard, giving each term in the claim its broadest reasonable construction consistent with the specification, and before any consideration is given to evidence which may be submitted in an attempt to establish a contrary conclusion of patentability.
- (c) The responsibility for compliance with this section rests upon the individuals designated in paragraph (a) of this section and no evaluation will be made by the Office in the reexamination proceeding as to compliance with this section. If questions of compliance with this section are raised by the patent owner or the third party requester during a reexamination proceeding, they will be noted as unresolved questions in accordance with § 1.552(c) .
[46 FR 29187, May 29, 1981, effective July 1, 1981; 47 FR 21752, May 19, 1982, effective July 1, 1982; paras. (a) and (b), 49 FR 556, Jan. 4, 1984, effective Apr. 1, 1984; revised 57 FR 2021, Jan. 17, 1992, effective Mar. 16, 1992; heading and para. (c) revised, 65 FR 76756, Dec. 7, 2000, effective Feb. 5, 2001]
Cited authority
Cited by
- 2001.01 Who Has Duty To Disclose
- 2001.04 Information Under 37 CFR 1.56(a)
- 2001.06(e) Information Relating to Regulatory Review
- 2014 Duty of Disclosure in Reexamination Proceedings and Supplemental Examination
- 2015 Duties of Disclosure and Reasonable Inquiry Arise in Dealings With Other Government Agencies
- 2202 Citation of Prior Art and Written Statements
- 2206 Submission and Handling of Prior Art or Section 301 Written Statements
- 2225 Untimely Paper Filed Prior to Order under 35 U.S.C. 304
- 2256 Prior Art Patents and Printed Publications Reviewed by Examiner in Reexamination
- 2257 Listing of Prior Art
- 2258 Scope of Ex Parte Reexamination
- 2271 Final Action
- 2280 Information Material to Patentability in Reexamination Proceeding Filed under 35 U.S.C. 302
- 2818 Procedure after Conclusion of Supplemental Examination
- 2818.01 After Determination Finding a Substantial New Question of Patentability
- 724 Trade Secret, Proprietary, and Protective Order Materials
- 724.03 Types of Trade Secret, Proprietary, and/or Protective Order Materials Submitted Under MPEP § 724.02
- 37 CFR 1.502 Processing of prior art citations during an ex parte reexamination proceeding
- 37 CFR 1.933 Patent owner duty of disclosure in inter partes reexamination proceedings